4,4'-(2,2-Diphenylethene-1,1-diyl)dibenzonitrile, 98%, 1g

N-Cyclohexyl-2-piperazin-1-yl-acetamide, 98.0%, 1g

Siliciuro di tantalio -325 mesh 99,5% 25 g

Methyl 1-benzyl-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate, 95.0%, 100mg

2-(4-Chloro-phenylsulfanylmethyl)-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

Methyl 6-bromo-2-fluoro-3-methylbenzoate, 97%, 5g

4,5-Dimethoxy-2-nitroaniline, 97%, 5g

Colonna capillare per GC ROTI®Cap-5, 15 m, 0.32 mm, 0.10 µm, 1 Pezzo(i)

N-(4-Fluorophenethyl)-4-(4-methyl-7-oxo-2-(p-tolyl)-2H-pyrazolo[3,4-d]pyridazin-6(7H)-yl)butanamide, 98.0%, 50mg

3-Oxabicyclo[3.2.0]heptane-2,4-dione, 97.0%, 1g

3-[2-(3,5-Dimethyl-1-piperidinyl)ethoxy]-benzaldehyde hydrochloride, 95.0%, 5g

(-)-alpha-Phellandrene>65.0%(GC)25mL

2,2'-((tert-Butoxycarbonyl)azanediyl)diacetic acid, 95.0%, 10g